Latest filingSep 22, 2026Most recent Form 4
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
NYSEHealthcarePharmaceutical Preparations
Insider activity for last month from 08/23 to 09/23. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$14.6M4 sells
Net open-market-$14.6M2 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period6transactions
- S · Open-market sells · dominant4 · 67%
- M · Option exercise2 · 33%
Activity by reported role
A joint filing can contribute to multiple roles6transactions
- CLO · dominant5 · 83%
- Director1 · 17%
Distinct insiders active
Reporting-owner CIKs by month · peak Sep 2026 (2)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeSavage BrianOrdinary Shares · Direct
15,842Sep 18, 2026
Mignone RobertoOrdinary Shares · Indirect · [see footnote]
0Sep 18, 2026
Savage BrianStock Options (right to buy) · Direct
0Sep 18, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 23 → Sep 23
LessMore
Top insiders
By absolute net value across the selected period- MR-$14.4M
- SB-$285.2k
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
No filing-only signal badges matched this period.
TEVA transaction history
Filters apply within this company and selected period by defaultLatest insider transactions
Form 4 filings from last month. Click any column to sort; click it again to flip the order.
| ID | Ticker | Insider | Role | Type | Shares | Value | Code | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|
| #227735 | TEVA | Savage Brian | CLO | exercise | 4.50k | -$15.6M | M | 09/22 | 09/18 |
| #227734 | TEVA | Savage Brian | CLO | sale | 314 | -$1.21M | S | 09/22 | 09/18 |
| #227733 | TEVA | Savage Brian | CLO | sale | 2.52k | -$9.88M | S | 09/22 | 09/18 |
| #227732 | TEVA | Savage Brian | CLO | sale | 4.50k | -$17.4M | S | 09/22 | 09/18 |
| #227731 | TEVA | Savage Brian | CLO | exercise | 4.50k | $15.6M | M | 09/22 | 09/18 |
| #227548 | TEVA | Mignone Roberto | DIR | sale | 367k | -$1.43B | S | 09/22 | 09/18 |
TEVA PHARMACEUTICAL INDUSTRIES LTD Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at TEVA PHARMACEUTICAL INDUSTRIES LTD?
Savage Brian, MIGNONE ROBERTO.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Savage Brian reported a sale on Sep 18, 2026 valued at $12.1k. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $14,642,016.99. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.